Hong Kong faces 'triple epidemic' as COVID, flu, RSV circulate simultaneously

Hong Kong's healthcare system is bracing for what medical experts are calling a perfect storm of respiratory illness. Three viruses—COVID-19, influenza, and respiratory syncytial virus—are circulating simultaneously through the population, and the worst may not have arrived yet. The flu season, which typically peaks later in the year, has not reached its maximum intensity, meaning hospitals and clinics should expect the pressure to intensify in the weeks ahead.

Mike Kwan Yat-wah, who leads the Asian Society for Paediatric Infectious Diseases and holds a clinical position at the University of Hong Kong, laid out the concern plainly during a radio interview on Saturday: the convergence of three major respiratory pathogens at once is straining the healthcare infrastructure in ways that single outbreaks do not. The warning carries particular weight because Kwan is not speculating—he is observing what is already happening in hospitals and clinics across the territory.

The urgency of the moment became starkly personal on August 4, when a seven-year-old boy died from influenza A. The child had been in good health before developing cold symptoms on July 27. A fever followed four days later, on August 1. Within two days of that fever, his condition collapsed. He died the next day, his body overwhelmed by influenza A infection that had triggered shock and encephalopathy—a dangerous swelling of the brain tissue. It was the first pediatric death from influenza in Hong Kong this year, a grim milestone that has refocused attention on how quickly these viruses can turn lethal, even in young, previously healthy children.

What made the death particularly notable—and troubling—was that the boy had received the seasonal influenza vaccine for the 2025/26 season. The Centre for Health Protection investigated and found no travel history during the incubation period, meaning the infection was acquired locally. Kwan offered a clinical explanation: antibody levels from vaccination can decline over time, and since the vaccination campaign had begun roughly six months before the boy's death, his immune protection may have waned. It is a reminder that vaccination, while crucial, is not an absolute shield, and that immunity requires ongoing attention.

Yet Kwan stopped short of calling the death a reason to lose faith in vaccination. Rather, he framed it as an isolated case—tragic, but not indicative of vaccine failure. Instead, he pointed to a broader challenge: the need for sustained, widespread vaccination coverage across the population, particularly among high-risk groups. Summer holidays are underway, but students continue attending extracurricular classes and group activities, creating ideal conditions for influenza to spread. Basic protective measures—masks, hand hygiene, attention to cleanliness while traveling—remain essential, Kwan emphasized.

The government is responding with a concrete step: the family doctor vaccine procurement pilot program, which has been supplying private physicians with doses, will expand for the 2026/27 season. The number of available vaccine doses for participating doctors will triple, from 100,000 to 300,000. Kwan welcomed the expansion, noting that awareness of flu prevention has grown and that private doctors are increasingly taking initiative to vaccinate vulnerable patients. But he called for more—stronger procurement efforts and more aggressive public education to push vaccination coverage higher.

The arithmetic is straightforward: three viruses, one healthcare system, and a population still in the early stages of what could be a severe season. The boy's death is a data point, but it is also a signal. What happens in Hong Kong over the next weeks will depend partly on how many people heed the warnings about vaccination and basic hygiene, and partly on how quickly the healthcare system can scale up to meet demand.